The therapeutic potential of regulatory T cells in reducing cardiovascular complications in patients with severe COVID-19

The SARS coronavirus 2 (SARS CoV-2) causes Coronavirus Disease (COVID-19), is an emerging viral infection. SARS CoV-2 infects target cells by attaching to Angiotensin-Converting Enzyme (ACE2). SARS CoV-2 could cause cardiac damage in patients with severe COVID-19, as ACE2 is expressed in cardiac cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Saghafi, Nafiseh, Rezaee, Seyed Abdolrahim, Momtazi-Borojeni, Amir Abbas, Tavasolian, Fataneh, Sathyapalan, Thozhukat, Abdollahi, Elham, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824166/
https://www.ncbi.nlm.nih.gov/pubmed/35149115
http://dx.doi.org/10.1016/j.lfs.2022.120392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824166/
https://www.ncbi.nlm.nih.gov/pubmed/35149115
http://dx.doi.org/10.1016/j.lfs.2022.120392

Ejemplares similares